(Q44149207)

30 November 2017

A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir (English)

1 reference

30 November 2017

Christelle Danve

1

1 reference

30 November 2017

Florence Morfin

series ordinal

2

1 reference

30 November 2017

Danielle Thouvenot

series ordinal

3

1 reference

30 November 2017

Michèle Aymard

series ordinal

4

1 reference

30 November 2017

1 September 2002

1 reference

Journal of Virological Methods

30 November 2017

1 reference

30 November 2017

105

1 reference

30 November 2017

2

1 reference

30 November 2017

207-217

1 reference

Simplified test for detecting the resistance of herpes simplex virus to acyclovir

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Herpes simplex virus antiviral drug resistance--current trends and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Dye Uptake Methods for Assessing Viral Cytopathogenicity and their Application to Interferon Assays

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Nucleic acid hybridization for measurement of effects of antiviral compounds on human cytomegalovirus DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Nucleic acid hybridization, a method to determine effects of antiviral compounds on herpes simplex virus type 1 DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Virus drug-resistance: mechanisms and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Standardisation of a microplate in situ ELISA (MISE-test) for the susceptibility testing of herpes simplex virus to acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Chronic recurrent acyclovir-resistant genital herpes in an immunocompetent patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Occurrence and characterization of acyclovir‐resistant herpes simplex virus isolates: Report on a two—year sensitivity screening survey

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Herpes simplex virus variants restraint to high concentrations of acyclovir exist in clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

A PLAQUE REDUCTION NEUTRALIZATION TEST FOR HUMAN CYTOMEGALOVIRUS

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

A rapid assay to screen for drug-resistant herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

A novel method for determining the sensitivity of herpes simplex virus to antiviral compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2802%2900103-9

7 January 2021

10.1016/S0166-0934(02)00103-9

Identifiers

DOI

1 reference

30 November 2017

1 reference